These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 206632)

  • 1. Effect of treatment with exogenous interferon, polyriboinosinic-polyribocytidylic acid, or polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex on Herpesvirus hominis infections in mice.
    Olsen GA; Kern ER; Overall JC
    J Infect Dis; 1978 Apr; 137(4):428-36. PubMed ID: 206632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice.
    Olsen GA; Kern ER; Glasgow LA; Overall JC
    Antimicrob Agents Chemother; 1976 Oct; 10(4):668-76. PubMed ID: 185951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment of vaccinia virus infection with an interferon inducer in rabbits.
    Levy HB; Lvovsky E
    J Infect Dis; 1978 Jan; 137(1):78-81. PubMed ID: 624854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine.
    Baer GM; Shaddock JH; Moore SA; Yager PA; Baron SS; Levy HB
    J Infect Dis; 1977 Aug; 136(2):286-91. PubMed ID: 408427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical polyriboinosinic-polyribocytidylic acid complex in the treatment of recurrent genital herpes.
    Crane LR; Levy HB; Lerner AM
    Antimicrob Agents Chemother; 1982 Mar; 21(3):481-5. PubMed ID: 7049075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice.
    Wong JP; Saravolac EG; Sabuda D; Levy HB; Kende M
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2574-6. PubMed ID: 8585749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
    Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
    Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
    Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
    Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
    Kende M
    J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.
    Levy HB; Riley FL; Lvovsky E; Stephen EE
    Infect Immun; 1981 Nov; 34(2):416-21. PubMed ID: 6171519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of interferon responses to poly ICLC in males and females.
    Bever CT; McFarlin DE; Levy HB
    J Interferon Res; 1985; 5(3):423-8. PubMed ID: 2414373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol induction by poly ICLC: implications for clinical trials of interferon.
    Bever CT; McFarland HF; Levy HB; McFarlin DE
    Ann Neurol; 1988 Feb; 23(2):196-9. PubMed ID: 2454067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol
    Kumaki Y; Salazar AM; Wandersee MK; Barnard DL
    Antiviral Res; 2017 Mar; 139():1-12. PubMed ID: 27956136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpesvirus saimiri: in vitro sensitivity to virus-induced interferon and to polyriboinosinic acid: polyribocytidylic acid.
    Barahona HH; Melendez LV
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1163-7. PubMed ID: 4324740
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.
    Kern ER; Olsen GA; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):344-6. PubMed ID: 206203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.
    Gatmaitan BG; Legaspi RC; Levy HB; Lerner AM
    Antimicrob Agents Chemother; 1980 Jan; 17(1):49-54. PubMed ID: 7352750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mouse interferon and polyriboinosinic acid-polyribocytidylic acid on L-cell tumor growth in nude mice.
    Clercq ED
    Cancer Res; 1977 May; 37(5):1502-6. PubMed ID: 856466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.
    Williams BB; Paul RT; Lerner AM
    J Infect Dis; 1982 Dec; 146(6):819-25. PubMed ID: 6183371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in mice.
    Imanishi J; Matsubara M; Won CJ; Nomura H; Kishida T
    Antimicrob Agents Chemother; 1981 May; 19(5):922-4. PubMed ID: 6170256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
    Sammons ML; Stephen EL; Levy HB; Baron S; Hilmas DE
    Antimicrob Agents Chemother; 1977 Jan; 11(1):80-3. PubMed ID: 402107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.